883TiP A phase I/II open-label study (IOV-GM1-201) of TALEN-mediated PD-1 inactivated autologous tumor-infiltrating lymphocytes (TIL; IOV-4001) in patients with advanced melanoma and NSCLC
| Autor: | J. Chesney, T. Wise-Draper, A.A. Sarnaik, F. Graf Finckenstein, P. Hari, M. Jagasia, A. Desai, A. Suzuki, X. Wu, A. Betof Warner |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Annals of Oncology. 33:S952 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2022.07.1009 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|